Michael Mendelsohn
Förmögenhet: - $ per 2026-06-30
Förmögenhet: - $ per 2026-06-30
Michael E.
Mendelsohn was the founder of Tufts Medical Center, Inc. (1998), where the title held was Chief Scientific Officer from 1998 to 2010.
Dr. Mendelsohn is the founder of Mendelsohn Consulting Group LLC (2013), holding the title of President since 2013.
Dr. Mendelsohn is the founder of Cardurion Pharmaceuticals, Inc. (2016), holding the titles of Chairman & Chief Strategy Officer since 2016.
Dr. Mendelsohn currently serves as Independent Director at Foghorn Therapeutics, Inc. since 2017.
Former jobs include Independent Director at Regado Biosciences, Inc. from 2014 to 2015; Independent Director at Cyclerion Therapeutics, Inc.; Chief Scientific Officer at Ironwood Pharmaceuticals, Inc. from 2014 to 2018; Member at The Brigham & Women's Hospital, Inc.; Senior VP & Global Head-Cardiovascular Research at Merck Research Laboratories Massachusetts LLC from 2010 to 2013; Venture Partner at SV Health Managers LLP from 2014 to 2017; Member at Harvard Medical School; Chief Scientific Officer at Tufts University School of Medicine from 2008 to 2010; Chief Medical & Scientific Officer at Takeda Pharmaceutical Co., Ltd. Education includes an undergraduate degree from Amherst College conferred in 1977 and a doctorate from Harvard Medical School conferred in 1982.
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
| 2026-04-20 | 0 ( -.--% ) | - $ | 2026-06-30 |
| Företag | Position | Start |
|---|---|---|
| FOGHORN THERAPEUTICS INC. | Direktör/Styrelseledamot | 2017-04-01 |
Cardurion Pharmaceuticals, Inc.
Cardurion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for the treatment of heart failure and cardiovascular diseases | Grundare | 2016-05-01 |
Mendelsohn Consulting Group LLC | Grundare | 2013-09-01 |
| Företag | Position | Slut |
|---|---|---|
| IRONWOOD PHARMACEUTICALS, INC. | Teknisk/Vetenskaplig/F&U Direktör | 2018-12-01 |
SV Health Managers LLP
SV Health Managers LLP Investment ManagersFinance SVHM is a hands-on manager which focuses investments in the human life sciences sector (biotechnology/biopharmaceuticals, medical devices, healthcare services and healthcare information technology). Their geographic focus is on North America and Western Europe, but they consider investment opportunities in other regions where there is a well-developed life sciences sector. SVHM's invests in companies with a very high quality management team and a business model that could provide a strong increase in value, often with a key technology protectable by law. They may occupy a strong, preferably proprietary position in a large or niche market or may have an early position in a fast growing market. | Företagsledare/Principal | 2017-07-01 |
Regado Biosciences, Inc.
Regado Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops antithrombotic drugs | Direktör/Styrelseledamot | 2015-05-01 |
Merck Research Laboratories Massachusetts LLC
Merck Research Laboratories Massachusetts LLC Pharmaceuticals: MajorHealth Technology Discovers, develops, and markets a broad range of human and animal health products | Företagsledare/Principal | 2013-11-01 |
Tufts Medical Center, Inc.
Tufts Medical Center, Inc. Hospital/Nursing ManagementHealth Services Offers academic medicine and research services | Grundare | 2010-05-01 |
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
| Privata företag | 14 |
|---|---|
Ironwood Pharmaceuticals, Inc.
Ironwood Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets gastrointestinal products | Health Technology |
Regado Biosciences, Inc.
Regado Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops antithrombotic drugs | Health Technology |
Takeda Pharmaceutical Co., Ltd.
Takeda Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Engages in the research, development, manufacturing and marketing of pharmaceutical products | Health Technology |
The Brigham & Women's Hospital, Inc.
The Brigham & Women's Hospital, Inc. Hospital/Nursing ManagementHealth Services Provides health care services | Health Services |
Amherst College
Amherst College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Tufts Medical Center, Inc.
Tufts Medical Center, Inc. Hospital/Nursing ManagementHealth Services Offers academic medicine and research services | Health Services |
Merck Research Laboratories Massachusetts LLC
Merck Research Laboratories Massachusetts LLC Pharmaceuticals: MajorHealth Technology Discovers, develops, and markets a broad range of human and animal health products | Health Technology |
SV Health Managers LLP
SV Health Managers LLP Investment ManagersFinance SVHM is a hands-on manager which focuses investments in the human life sciences sector (biotechnology/biopharmaceuticals, medical devices, healthcare services and healthcare information technology). Their geographic focus is on North America and Western Europe, but they consider investment opportunities in other regions where there is a well-developed life sciences sector. SVHM's invests in companies with a very high quality management team and a business model that could provide a strong increase in value, often with a key technology protectable by law. They may occupy a strong, preferably proprietary position in a large or niche market or may have an early position in a fast growing market. | Finance |
Harvard Medical School
Harvard Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Tufts University School of Medicine
Tufts University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Foghorn Therapeutics, Inc.
Foghorn Therapeutics, Inc. BiotechnologyHealth Technology Discovers and develops novel drugs to treat cancer and other serious medical disorders | Health Technology |
Cardurion Pharmaceuticals, Inc.
Cardurion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for the treatment of heart failure and cardiovascular diseases | Health Technology |
Cyclerion Therapeutics, Inc.
Cyclerion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and distributes pharmaceutical products for serious and orphan diseases | Health Technology |
Mendelsohn Consulting Group LLC |
Välj din utgåva
All finansiell information anpassad till den nationella nivån